Clinical Trial Update: Role of Regulatory B Cells in the Pathogenesis of Metabolic Associated Fatty Liver Disease

View source ↗

Summary

A recruiting clinical trial examining whether regulatory B cells contribute to the development of metabolic dysfunction-associated fatty liver disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Fatty Liver Disease
• Non-alcoholic Fatty Liver Disease

Snippet

Sponsor: Assiut University | Conditions: Non-Alcoholic Fatty Liver Disease | Status: RECRUITING